Literature DB >> 20573790

Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged > or =60 y in the United States.

Regan L Bailey1, James L Mills, Elizabeth A Yetley, Jaime J Gahche, Christine M Pfeiffer, Johanna T Dwyer, Kevin W Dodd, Christopher T Sempos, Joseph M Betz, Mary Frances Picciano.   

Abstract

BACKGROUND: Unmetabolized serum folic acid (UMFA) has been detected in adults. Previous research indicates that high folic acid intakes may be associated with risk of cancer.
OBJECTIVE: The objective was to examine UMFA concentrations in relation to dietary and supplemental folate and status biomarkers in the US population aged > or =60 y.
DESIGN: Surplus sera were analyzed with the use of data from the National Health and Nutrition Examination Survey (NHANES) 2001-2002, a cross-sectional, nationally representative survey (n = 1121).
RESULTS: UMFA was detected in 38% of the population, with a mean concentration of 4.4 +/- 0.6 nmol/L (median: 1.2+/- 0.2 nmol/L). The group with UMFA (UMFA+) had a significantly higher proportion of folic acid supplement users than did the group without UMFA (60% compared with 41%). UMFA+ men and women also had higher supplemental and total (food + supplements) folic acid intakes than did their counterparts without UMFA. Forty percent of the UMFA+ group was in the highest quartile of total folic acid intake, but total folic acid intake was only moderately related to UMFA concentrations (r(2) = 0.07). Serum folate concentrations were significantly higher in the UMFA+ group and were predictive of UMFA concentrations (r(2) = 0.15). Serum 5-methyltetrahydrofolate and vitamin B-12 concentrations were higher in the UMFA+ group, whereas there was no difference between the 2 UMFA groups in red blood cell folate, serum homocysteine, or methylmalonic acid concentrations.
CONCLUSIONS: Approximately 40% of older adults in the United States have UMFA that persists after a fast, and the presence of UMFA is not easily explained in NHANES by folic acid intakes alone. Given the possibility that excessive folic acid exposure may relate to cancer risk, monitoring of UMFA may be warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573790      PMCID: PMC2904036          DOI: 10.3945/ajcn.2010.29499

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  26 in total

1.  Analysis of folate form distribution by affinity followed by reversed- phase chromatography with electrical detection.

Authors:  P J Bagley; J Selhub
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

2.  Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements.

Authors:  P Kelly; J McPartlin; M Goggins; D G Weir; J M Scott
Journal:  Am J Clin Nutr       Date:  1997-06       Impact factor: 7.045

3.  Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors.

Authors:  Martha Savaria Morris; Paul F Jacques; Irwin H Rosenberg; Jacob Selhub
Journal:  Am J Clin Nutr       Date:  2010-03-31       Impact factor: 7.045

4.  The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States.

Authors:  Marion Dietrich; Coralie J P Brown; Gladys Block
Journal:  J Am Coll Nutr       Date:  2005-08       Impact factor: 3.169

5.  Simultaneous quantification of homocysteine and folate in human serum or plasma using liquid chromatography/tandem mass spectrometry.

Authors:  Bryant C Nelson; Mary B Satterfield; Lorna T Sniegoski; Michael J Welch
Journal:  Anal Chem       Date:  2005-06-01       Impact factor: 6.986

Review 6.  Will mandatory folic acid fortification prevent or promote cancer?

Authors:  Young-In Kim
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

7.  Biotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis-Menten kinetics.

Authors:  M Lucock; J Wild; R Smithells; R Hartley
Journal:  Eur J Clin Nutr       Date:  1989-09       Impact factor: 4.016

Review 8.  Modeling the level of fortification and post-fortification assessments: U.S. experience.

Authors:  Elizabeth A Yetley; Jeanne I Rader
Journal:  Nutr Rev       Date:  2004-06       Impact factor: 7.110

9.  Solid-phase extraction-electrospray ionization mass spectrometry for the quantification of folate in human plasma or serum.

Authors:  Bryant C Nelson; Christine M Pfeiffer; Sam A Margolis; Chad P Nelson
Journal:  Anal Biochem       Date:  2004-02-01       Impact factor: 3.365

10.  Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.

Authors:  E Giovannucci; M J Stampfer; G A Colditz; D J Hunter; C Fuchs; B A Rosner; F E Speizer; W C Willett
Journal:  Ann Intern Med       Date:  1998-10-01       Impact factor: 25.391

View more
  35 in total

1.  Presence of circulating folic acid in plasma and its relation with dietary intake, vitamin B complex concentrations and genetic variants.

Authors:  Josiane Steluti; Christina Reginaldo; Jacob Selhub; Ligi Paul; Regina Mara Fisberg; Dirce Maria Marchioni
Journal:  Eur J Nutr       Date:  2018-11-02       Impact factor: 5.614

2.  Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers.

Authors:  Marian L Neuhouser; H Frederik Nijhout; Jesse F Gregory; Michael C Reed; S Jill James; Amy Liu; Barry Shane; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-13       Impact factor: 4.254

3.  Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States.

Authors:  Todd M Gibson; Stephanie J Weinstein; Ruth M Pfeiffer; Albert R Hollenbeck; Amy F Subar; Arthur Schatzkin; Susan T Mayne; Rachael Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2011-08-03       Impact factor: 7.045

4.  Dietary folic acid protects against genotoxicity in the red blood cells of mice.

Authors:  Amanda J MacFarlane; Nathalie A Behan; Martha S Field; Andrew Williams; Patrick J Stover; Carole L Yauk
Journal:  Mutat Res       Date:  2015-06-29       Impact factor: 2.433

Review 5.  Best Practices for Dietary Supplement Assessment and Estimation of Total Usual Nutrient Intakes in Population-Level Research and Monitoring.

Authors:  Regan L Bailey; Kevin W Dodd; Jaime J Gahche; Johanna T Dwyer; Alexandra E Cowan; Shinyoung Jun; Heather A Eicher-Miller; Patricia M Guenther; Anindya Bhadra; Paul R Thomas; Nancy Potischman; Raymond J Carroll; Janet A Tooze
Journal:  J Nutr       Date:  2019-02-01       Impact factor: 4.798

6.  Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake.

Authors:  Hathairat Sawaengsri; Peter R Bergethon; Wei Qiao Qiu; Tammy M Scott; Paul F Jacques; Jacob Selhub; Ligi Paul
Journal:  Am J Clin Nutr       Date:  2016-10-12       Impact factor: 7.045

7.  Intergenerational impact of paternal lifetime exposures to both folic acid deficiency and supplementation on reproductive outcomes and imprinted gene methylation.

Authors:  Lundi Ly; Donovan Chan; Mahmoud Aarabi; Mylène Landry; Nathalie A Behan; Amanda J MacFarlane; Jacquetta Trasler
Journal:  Mol Hum Reprod       Date:  2017-07-01       Impact factor: 4.025

8.  Folate.

Authors:  Yen-Ming Chan; Regan Bailey; Deborah L O'Connor
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

9.  Supplemental dietary folic acid has no effect on chromosome damage in erythrocyte progenitor cells of mice.

Authors:  Breanne G Swayne; Nathalie A Behan; Andrew Williams; Patrick J Stover; Carole L Yauk; Amanda J MacFarlane
Journal:  J Nutr       Date:  2012-03-21       Impact factor: 4.798

Review 10.  Molecular mechanisms underlying the potentially adverse effects of folate.

Authors:  Kyle C Strickland; Natalia I Krupenko; Sergey A Krupenko
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.